bcdiabetes.ca, Author at BCDiabetes

Petition: Lobby BC Pharmacare to cover lifesaving SGLT2 inhibitor diabetes treatment

Living With Diabetes

BCDiabetes Medical Director, Dr. Tom Elliott, has launched a petition to lobby BC Pharmacare to cover SGLT2 inhibitors. As many as 50,000 British Columbians would likely benefit from SGLT2 inhibitors, but many do not have funds or coverage. This class of drug has been shown to reduce mortality for those at high risk of heart […]

READ MORE

BC is a third-world country when it comes to covering life-saving medication for diabetes

Research

A life saving class of diabetes oral medication, SGLT2 inhibitors, costing less than $3/day, is not covered in British Columbia, but is covered in the rest of Canada.  I asked Dr. Elliott, Medical Director of BCDiabetes.ca for his comments.  Dr. Elliott has already blogged twice on this class of medication (see https://www.bcdiabetes.ca/third-sglt2-inhibitor-in-canada/ & https://www.bcdiabetes.ca/empa-reg-outcome-renal/ Dr. […]

READ MORE

Closer to the Artificial Pancreas

Research,Technology

The US Food and Drug Administration (FDA) approved the first closed-loop insulin-pump sensor system for the diabetes market.  The MiniMed 670G hybrid closed looped system, often referred to as an “artificial pancreas,” is intended to adjust insulin levels with little or no input from the user. It works by measuring glucose levels every five minutes and automatically […]

READ MORE

Get Ready for the Freestyle Libre

Living With Diabetes,Technology

Last week the prestigious British medical journal the Lancet published a report summarized here describing dramatic reductions in low blood sugar without any loss of blood sugar control using the Freestyle Libre.   “The Freestyle Libre is the first of a new class of glucose monitoring devices that use “flash” technology.  These devices measure sugar/glucose in the […]

READ MORE

New Study Questions Effectiveness of Type 2 Diabetes Treatment

Living With Diabetes,Research

New study questions Type 2 diabetes treatment “No evidence glucose-lowering drugs help ward off long-term complications, researchers say.” This is a massive statement so we sought our medical director, Dr. Tom Elliott, for insight.   The CBC recently reported on a publication by Dr. Victor Montori, of the Mayo Clinic in Circulation: Cardiovascular Quality and Outcomes arguing a […]

READ MORE

E-cigarettes as Aids in Quitting Smoking

Research

Via Reuters, electronic cigarettes may have helped about 18,000 people in England to give up smoking last year and there is no evidence of any serious side effects associated with their use for up to two years, according to studies published on Tuesday. “For cigarette smokers smoking cessation remains the biggest and most powerful positive health […]

READ MORE

Rethinking Investment in Healthcare

News & Media,Technology

BCDiabetes Medical Director, Dr. Tom Elliott, recently met with Shafin Tejani, Angel Investor of the Year at the 2015 Canadian Startup Awards, to discuss a diabetes-related innovation. While the notion of money and investment in healthcare is nothing new, that diabetes is seen as a cause in addition to a market by people such as […]

READ MORE

What Is Good For Athletes Is Good For People With Diabetes

Research

A recent article shows that superior performance can be achieved by professional cyclists using ketones as preferred fuel rather than traditional carbohydrate or fat. This information comes hard on the heels of exciting new evidence for the benefits of the sglt2 inhibitor class of drugs in Type 2 diabetes. It may well be that they these […]

READ MORE

Diabetes is No Laughing matter

Living With Diabetes

Have you seen “diabetes” memes? They might show up as candy lasagna or math problems such as “Johnny has 20 candy bars. He eats 12. What does Johnny have?” On one hand, these are a clear indication that the general public is understanding that diet can play a factor in the likelihood of developing Type 2 diabetes, […]

READ MORE

Role of Self-Compassion in Diabetes Control

Living With Diabetes,Research

A recent randomized control trial involving a mindful, self-compassion (MSC) intervention showed that that the intervention “increased self-compassion and produced statistically and clinically significant reductions in depression and diabetes distress in the intervention group, with results maintained at 3-month follow-up.” In addition, MSC participants showed a decrease in A1c versus the control group. At BCDiabetes we […]

READ MORE
Translate »